Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 1188
Special Issue Editors
Interests: pharmacology and pharmaceutical sciences; biochemistry and cell biology; gene and molecular therapy; neurosciences; microfluidics and nanofluidics
Interests: nanofabrication approaches for oral drug delivery; electrospinning; solid dispersions; physical characterization techniques; microfluidics; nanogels for gene delivery; taste masked dosage forms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Adeno-associated virus (AAV) has emerged as one of the most important vectors in modern gene therapy, enabling long-lasting, tissue-targeted delivery with a strong safety profile. AAV gene therapy has revolutionised treatment for some diseases, but remains limited by its high cost, variable efficacy, and translational uncertainty. As clinical demand for AAV grows, advancing its bioprocessing and engineering is essential to overcome its current limitations in terms of potency, specificity, manufacturability, and scalability. This Special Issue of Pharmaceutics highlights innovations in AAV engineering and manufacturing, from designing next-generation capsids with enhanced tropism and transduction efficiency and reduced immunogenicity, to optimising upstream production systems and downstream purification workflows that maximise yield and product quality. We welcome studies that apply synthetic biology, high-throughput screening, and computational design to engineer improved vectors, as well as work that develops robust analytical tools, stable formulations, and regulatory-ready CMC strategies. By integrating biological insight with bioengineering advances, this Special Issue aims to accelerate the development of more effective, scalable, and accessible AAV-based therapeutics.
Dr. Giulia Massaro
Prof. Dr. Duncan Craig
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- AAV
- gene therapy
- viral vector
- capsid engineering
- bioprocessing
- synthetic biology
- computational design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
